Anne Paccaly

6PUBLICATIONS
56CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsInnate immunityGene and molecular therapyPharmacogenomics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Oct 18, 2024
First-in-Human Dose-Escalation Study of Fianlimab, an Antilymphocyte Activation Gene-3 Antibody, with Cemiplimab in Patients with Advanced Malignancies.

Nehal J Lakhani, Kyriakos P Papadopoulos, Melissa Lynne Johnson

|Jun 20, 2024
Phase I Study of Fianlimab, a Human Lymphocyte Activation Gene-3 (LAG-3) Monoclonal Antibody, in Combination With Cemiplimab in Advanced Melanoma.

Omid Hamid, Karl D Lewis, Amy Weise

|Mar 07, 2024
Safety and Immune Responses Following Anti-PD-1 Monoclonal Antibody Infusions in Healthy Persons With Human Immunodeficiency Virus on Antiretroviral Therapy.

Cynthia L Gay, Ronald J Bosch, Ashley McKhann

|Dec 14, 2023
Subcutaneous Administration of Monoclonal Antibodies: Pharmacology, Delivery, Immunogenicity, and Learnings From Applications to Clinical Development.

John D Davis, Marçal Bravo Padros, Daniela J Conrado

|Mar 26, 2021
Fixed Dose of Cemiplimab in Patients with Advanced Malignancies Based on Population Pharmacokinetic Analysis.

Anne J Paccaly, Michael R Migden, Kyriakos P Papadopoulos

|Jul 30, 2020
Pharmacokinetics and Pharmacodynamics of Subcutaneous Sarilumab and Intravenous Tocilizumab Following Single-Dose Administration in Patients With Active Rheumatoid Arthritis on Stable Methotrexate.

Anne J Paccaly, Pavel Kovalenko, Janie Parrino

Pageof 1

Frequent Collaborators

2 joint publications

Glenn Kroog

2 joint publications

Jayakumar Mani

2 joint publications

Nehal J Lakhani

2 joint publications

Kyriakos P Papadopoulos